Association of SCNN1A Single Nucleotide Polymorphisms With Neonatal Respiratory Distress Syndrome
Sponsor: Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
Listed as NCT02333669, this observational or N/A phase trial focuses on Neonatal Respiratory Distress Syndrome and remains completed. Sponsored by Daping Hospital and the Research Institute of Surgery of the Third Military Medical University, it has been updated 6 times since 2012, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
6 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Jan 2021 — Jul 2024 [monthly]
Completed
-
Jun 2018 — Jan 2021 [monthly]
Completed
-
Apr 2018 — Jun 2018 [monthly]
Completed
Phase: NA → None
▶ Show 1 earlier version
-
Jan 2017 — Apr 2018 [monthly]
Completed NA
First recorded
Jan 2012
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
For direct contact, visit the study record on ClinicalTrials.gov .